• Thu, May 23, 2019
  • Fri, May 24, 2019
  • Tue, May 28, 2019
  • Wed, May 29, 2019

Laura Chico Initiated (BIIB) at Hold and Held Target at $231 on, May 23rd, 2019

Laura Chico of Wedbush, Initiated "Biogen Inc." (BIIB) at Hold and Held Target at $231 on, May 23rd, 2019.

Laura has made no other calls on BIIB in the last 4 months.



There are 14 other peers that have a rating on BIIB. Out of the 14 peers that are also analyzing BIIB, 11 agree with Laura's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $245 on, Thursday, May 9th, 2019
  • Sumant Kulkarni of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $275 on, Friday, March 22nd, 2019
  • Carter Gould of "UBS" Downgraded from Strong Buy to Hold on, Friday, March 22nd, 2019
  • Robyn Karnauskas of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $230 on, Friday, March 22nd, 2019
  • Salim Syed of "Mizuho" Downgraded from Strong Buy to Hold and Decreased Target to $235 on, Friday, March 22nd, 2019
  • Steve Chesney of "Atlantic Equities" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Alethia Young of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Matt Phipps of "William Blair" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Ian Somaiya of "BMO Capital" Initiated at Hold and Held Target at $322 on, Friday, February 22nd, 2019
  • Adnan Butt of "Guggenheim" Downgraded from Strong Buy to Hold and Decreased Target to $325 on, Friday, February 22nd, 2019
  • Thomas Shrader of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $346 on, Thursday, February 21st, 2019


These are the ratings of the 3 analyists that currently disagree with Laura


  • Evan Seigerman of "Credit Suisse" Initiated at Sell and Held Target at $198 on, Tuesday, May 21st, 2019
  • Christopher Marai of "Nomura" Maintained at Strong Buy with Decreased Target to $320 on, Friday, March 22nd, 2019
  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Sell on, Friday, March 22nd, 2019

Like: 👍